金屬硫蛋白1(MT1)多克隆抗體
Polyclonal Antibody to Metallothionein 1 (MT1)
MT1A; MT1S; MTC
- 編號(hào)PAB119Rb52
 - 物種Oryctolagus cuniculus (Rabbit,兔)相同的名稱(chēng),不同的物種。
 - 來(lái)源多抗制備
 - 宿主豚鼠
 - 效價(jià)-
 - Ig類(lèi)型IgG
 - 純化方式抗原特異性親和純化
 - 標(biāo)記物別藻藍(lán)蛋白
 - 免疫原-
 - 緩沖液成份磷酸鹽緩沖液(pH7.4,含有0.02% NaN3和50%甘油)
 - 性狀液體
 - 濃度500μg/mL
 - 且適物種-
 - 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù),請(qǐng)參見(jiàn)流式抗體。 - 下載英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
 - 規(guī)格20μl100μl200μl1ml10ml
 - 價(jià)格¥ 652¥ 1520¥ 2172¥ 5430¥ 21720
 - 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷(xiāo)商聯(lián)系!
 
特異性
該抗體是針對(duì)MT1的豚鼠多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別MT1。
用法
                        免疫印跡:0.2-2μg/mL;1:250-2500
                        
 免疫組織化學(xué):5-20μg/mL;1:25-100
                        
 免疫細(xì)胞化學(xué):5-20μg/mL;1:25-100
                        
 最佳稀釋倍數(shù)最終由用戶(hù)決定。
                        
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過(guò)兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽(yáng)性對(duì)照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長(zhǎng)臂生物素標(biāo)記試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種:Oryctolagus cuniculus (Rabbit,兔) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| PAB119Rb51 | 金屬硫蛋白1(MT1)多克隆抗體 | WB; IHC; ICC; IP. | 
| PAB119Rb52 | 金屬硫蛋白1(MT1)多克隆抗體 | WB; IHC; ICC; IP. | 
| LAB119Rb71 | 金屬硫蛋白1(MT1)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| Biotechology letters | Modulated expression of genes associated with NO signal transduction contributes to the cholesterol-lowering effect of electro-acupuncture[SpringerLink: c1v4234150886817] | 
| International Journal of Diabetes in Developing Countries | Evaluation of serum metallothionein-1, selenium, zinc, and copper in Ghanaian type 2 diabetes mellitus patients[Springer: Source] | 
| Experimental Oncology | Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin[Pubmed:25265354] | 
| Journal of Neurochemistry | Neuroprotective?effects?of?levetiracetam?target?xCT?in?astrocytes?in?parkinsonian?mice.[Pubmed:26485447] | 
| Toxicology Mechanisms and Methods | Evaluation of hepatorenal impairments in Wistar rats coexposed to low-dose lead, cadmium and manganese: insights into oxidative stress mechanism[pubmed:27599793] | 
| Environmental toxicology and pharmacology | Dyslipdemia induced by chronic low dose co-exposure to lead, cadmium and manganese in rats: the role of oxidative stress[pubmed:28654832] | 
| European?Journal?of?Immunology | Metallothionein‐1 suppresses rheumatoid arthritis pathogenesis by shifting the Th17/Treg balance[Pubmed:30055006] | 
| Int Immunopharmacol | Metallothionein-1 is associated with osteoarthritis disease activity and suppresses proinflammatory cytokines production in synovial cells[Pubmed: 31465913] | 
| Influence of cadmium on blood and hair trace elements and biochemical markers[] | 


